Loading clinical trials...
Loading clinical trials...
Study of Efficacy of Zoledronic Acid in the Management of Osteoporosis in Children With Multiple Disabilities
The main purpose of this study is the evaluation of the efficacy of zoledronic acid on bone density in children with osteoporosis caused by multiple disabilities. Secondary purposes are: 1. Description of child population with osteoporosis in the context of motor impairment in Lorraine region 2. Description of osteoporosis stage (level of bone mineralization and clinical consequences) in children with multiple disabilities 3. Description of current osteoporosis preventive care 4. Description of risk factors associated to bone status (drugs) 5. Evaluation of zoledronic acid treatment on fracture numbers 6. Evaluation of zoledronic acid on phosphocalcic profile 7. Description of side effects of zoledronic acid in this indication 8. Description of treatment effects in the sub-population of children with Rett syndrome.
Age
0 - 18 years
Sex
ALL
Healthy Volunteers
No
Children's Hospital - CHRU de Nancy
Vandœuvre-lès-Nancy, France
Start Date
January 1, 2017
Primary Completion Date
March 31, 2017
Completion Date
March 31, 2017
Last Updated
October 4, 2017
60
ACTUAL participants
Zoledronic Acid
DRUG
Lead Sponsor
Central Hospital, Nancy, France
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT07281586